Access cutting-edge primary membranous nephropathy treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.
Access primary membranous nephropathy specialists in Detroit at no cost
This study follows strict safety protocols and ethical guidelines
All study-related primary membranous nephropathy treatment provided free
In this study, researchers will learn more about the use of felzartamab in participants with primary membranous nephropathy, also known as PMN. In people with PMN, autoantibodies build up in the glomeruli of the kidney. Antibodies are proteins that help the body fight off infection. An autoantibody is a type of antibody that mistakenly targets and attacks the body's own tissues. Glomeruli are the filters of the kidney that remove waste and extra fluid from the body. In PMN, the build-up of autoa
Sponsor: Biogen
Check if you qualify for this primary membranous nephropathy clinical trial in Detroit, MI
If you're searching for primary membranous nephropathy treatment options in Detroit, MI, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced primary membranous nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.